Rayno Life Science Portfolios:Illumina (ILMN) and Seattle Genetics(SGEN)
Reviewing Today’s Action A mixed market today with a slight edge to the bulls. Immunogen(IMGN $12.28) up 4% continues its run from yesterday on positive data from its collboration with Roche on T-DM1 (trastuzumab) an antibody coupled with a cell killing agent (chemotherapy) from Immunogen showing improvement in progression-free survival in breast cancer patients. Seattle Genetics(SGEN) [...]
